TCF7L2 rs4363657: Understanding Your Genetic Risk for Diabetes
The rs4363657 variant is a common genetic marker located within the TCF7L2 gene, which is widely recognized as one of the most significant genetic loci associated with type 2 diabetes risk. Research indicates that variations in this region may influence how the body processes insulin and manages glucose levels.
What each genotype means
Lower diabetes risk profile
This genotype is considered the non-risk or protective version of this variant. Research indicates that individuals with this genotype generally have a lower statistical risk of developing type 2 diabetes compared to those carrying the T allele.
This is a common genotype found in most global populations, though frequencies vary by ancestry.
Increased diabetes risk profile
Carrying one copy of the T allele is associated with a statistically higher risk of developing type 2 diabetes. This variant is linked to potential changes in insulin secretion and glucose metabolism, though it is not a diagnostic indicator of disease.
This heterozygous genotype is frequently observed across diverse populations worldwide.
Higher diabetes risk profile
Carrying two copies of the T allele is associated with the highest statistical risk for type 2 diabetes among the common genotypes for this variant. Research suggests this may be linked to impaired insulin secretion and altered glucose regulation, but this is a risk factor rather than a medical diagnosis.
This homozygous genotype is less common than the heterozygous form but is present in a significant portion of the population across many ancestries.
What is rs4363657 and Where is it Located?
The variant rs4363657 is a single nucleotide polymorphism (SNP) situated within the TCF7L2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The TCF7L2 gene is located on chromosome 10 and provides instructions for making a protein that acts as a transcription factor, which helps control the activity of other genes. Because rs4363657 is located in a non-coding region of the gene, it does not change the structure of the TCF7L2 protein itself. Instead, it is thought to influence how much of the protein is produced or how the gene is regulated within specific tissues, such as the pancreas. Scientists study these markers to understand the complex genetic architecture that contributes to metabolic health and disease susceptibility.
The Role of the TCF7L2 Gene
The TCF7L2 gene is a critical component of the Wnt signaling pathway, which is essential for cell development and maintenance. In the context of metabolism, TCF7L2 is highly expressed in the pancreatic islets, the clusters of cells responsible for producing insulin. Research suggests that the gene plays a vital role in the function of beta-cells, which are the specific cells that secrete insulin in response to rising blood glucose levels. When TCF7L2 expression is altered, it may impair the ability of these cells to secrete insulin effectively. Studies have shown that increased expression of TCF7L2 in human islets can lead to reduced glucose-stimulated insulin secretion, potentially contributing to the development of hyperglycemia and type 2 diabetes over time.
Research Associations and Evidence Strength
The association between TCF7L2 variants and type 2 diabetes is considered robust and well-replicated across diverse populations. While rs4363657 is a marker within this locus, the broader TCF7L2 region is frequently cited as the most potent genetic risk factor for type 2 diabetes identified to date. Large-scale genome-wide association studies (GWAS) have consistently linked these variants to an increased risk of developing the condition, often by 30% to 50% per risk allele inherited. The evidence is considered moderate to strong because the findings have been reproduced in multiple cohorts, including Scandinavian, European, and American populations. However, it is important to note that genetic risk is only one piece of the puzzle; environmental factors, lifestyle, and other genetic variants also play significant roles in the overall risk of developing diabetes.
Population Frequency
The rs4363657 variant is classified as a common polymorphism, meaning it is found frequently across many different ancestral groups. Because it is common, a large portion of the global population carries at least one copy of the variant. Its prevalence does not imply that all carriers will develop diabetes, but rather that it is a widespread genetic feature that contributes to the baseline risk profile within human populations.
What You Can and Cannot Do With This Information
Understanding your genetic profile regarding rs4363657 can provide insight into your biological predisposition, but it is not a diagnostic tool. A genetic variant is not a medical diagnosis, and having a risk-associated genotype does not guarantee that you will develop type 2 diabetes. Conversely, not having the variant does not eliminate the risk. This information should be viewed as a single data point in the context of your overall health, including diet, physical activity, and family history. You cannot use this information to self-diagnose or alter medical treatments. If you are concerned about your risk for diabetes or have questions about your metabolic health, you should consult with a healthcare professional. They can provide appropriate screenings, such as blood glucose or HbA1c tests, and offer personalized guidance based on your clinical history.
How common is this variant?
The rs4363657 variant is a common polymorphism found across diverse global populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Does having the TCF7L2 risk variant mean I will get diabetes?
No, having a risk variant does not mean you will develop diabetes. Genetic risk is only one factor, and many people with the variant never develop the condition, while others without it do.
Can I change my genetic risk for diabetes?
You cannot change your DNA, but you can influence your health outcomes. Lifestyle factors such as maintaining a healthy weight, regular physical activity, and a balanced diet are known to significantly reduce the risk of type 2 diabetes, regardless of your genetic background.
Should I get tested for rs4363657?
Genetic testing for common variants like rs4363657 is generally not recommended for clinical diagnosis. If you are concerned about your diabetes risk, it is more effective to speak with a doctor about standard clinical screenings like blood glucose testing.
How does TCF7L2 affect insulin?
Research suggests that TCF7L2 variants may impair the function of pancreatic beta-cells. This can lead to reduced insulin secretion in response to glucose, which is a key mechanism in the development of type 2 diabetes.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4363657?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.